|Publication number||US6918766 B1|
|Application number||US 09/980,009|
|Publication date||Jul 19, 2005|
|Filing date||May 23, 2000|
|Priority date||May 31, 1999|
|Also published as||CA2373703A1, CA2373703C, DE60031991D1, DE60031991T2, EP1207802A1, EP1207802B1, WO2000072778A1|
|Publication number||09980009, 980009, PCT/2000/1029, PCT/SE/0/001029, PCT/SE/0/01029, PCT/SE/2000/001029, PCT/SE/2000/01029, PCT/SE0/001029, PCT/SE0/01029, PCT/SE0001029, PCT/SE001029, PCT/SE2000/001029, PCT/SE2000/01029, PCT/SE2000001029, PCT/SE200001029, US 6918766 B1, US 6918766B1, US-B1-6918766, US6918766 B1, US6918766B1|
|Inventors||Jan Hall, Lennart Lööf|
|Original Assignee||Nobel Biocare Ab|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (18), Referenced by (22), Classifications (23), Legal Events (5)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to a method for use in connection with an implant for bone and/or tissue structure, for example dentine, and ensuring delivery of bioactive substance to the structure during all or part of the period of incorporation of the implant. The invention also relates to an arrangement and use of such an implant and such delivery.
In connection with implants, it is already known to use various types of bioactive substances intended to improve the incorporation of the implant in the bone or tissue in question. Thus, for example, it may be desirable to use a substance belonging to the superfamily TGF-β, for example so-called BMP (Bone Morphogenetic Proteins) in order to initiate and stimulate bone growth. Reference may be made here to patent publications WO 95/33502, WO 96/40014 and WO 98/17330, among others.
Implants and implant elements and methods for permanent anchoring in mineralized tissue have been known for a long time. To prevent the implant from coming loose, it is important to establish direct contact (i.e. direct application) between the outer surface of the implant or implant element and the surrounding body tissue. When direct application has indeed been established, the implant is stable, and so-called osseointegration can be obtained. Direct contact between the surface of the implant element and the bone tissue can be obtained by means of a suitable implant structure and refined surgical technique. The principle of osseointegration has been developed by Professor Bránemark et al. and has been used successfully in the treatment of edentulous patients with dental implants for many years.
The treatment of edentulous patients usually includes careful patient selection, a detailed surgical protocol, and careful planning of the prosthetic constructions which are to be used. The most successful clinical results have been achieved after treatment of patients with tight, compact bone in which it is fairly easy to obtain stable fixation of the implant. However, less successful results have been reported after treatment in bone of softer quality. The difficulties have manifested themselves in the break-up of a stable implant fixation. Various methods have been proposed to overcome these difficulties. These methods generally involve using additional new means for implant surfaces, for example coating with hydroxyapatite, or preparation of implant surface irregularities which have been judged to improve the implant fixation. Very little is in fact known of the relative importance of implant geometry, chemical surface properties and surface irregularities. However, implant geometry probably plays an important role, since it has a strong influence on the load distribution in the tissue surrounding the implant body.
Running parallel with the development of different types of implants, investigations have been conducted with the aim of characterizing the interaction of cells and cellular molecules in living tissue. Detailed analysis of the interaction at the cellular and molecular level has been found to be fundamental for the development of the modern pharmaceutical industry and genetic engineering. However, such knowledge could also be successfully used in the development of load-bearing implants in bone. When the mechanisms of interaction are known, it may be possible to act on the processes of interaction and the possibilities of stimulating bone growth and increasing bone density and bone volume in or at the implant site in the body. This is often a precondition for stable implant fixation in less than optimal circumstances with soft bone qualities.
A particular example of acting on bone growth and increasing bone density is the use, as mentioned above, of bioactive substances. Growth factors can stimulate bone growth in a known manner, provided that they are released into the surrounding tissue at a sufficient concentration and speed for a fairly long period of time after their introduction.
Insofar as reference is made to the said Bránemark system, reference may also be made, inter alia, to European Patent Application 95102381.1 (676179).
Implants as such are already very well known and are commercially available in large numbers and in many different ranges. Implants which are relevant in this context are disclosed, for example, in U.S. Pat. No. 4,960,301, as well as implants which are shown in the publication “Oral Implantology” which relates to “ITI Hollow Cylinder System”, published 1991 by Georg Thieme Verlag, Stuttgart and New York.
Studying and/or acting on the anchoring of implants in living biological tissues under variable conditions, especially in the form of reaction to locally applied substances, is the subject of European Patent Specification 720833. This arrangement comprises an anchoring element which is to be incorporated in the tissue. It has a central recess in the form of a depot for the substance in question. The surface of the anchoring element adjoining the tissue consists entirely or partially of penetrable material or “filter” which allows the applied substance to diffuse out onto the implant surface, or into the biological fluid around the implant surface, from a central recess. Although it is stated that such an anchoring element would simulate clinically produced implants with respect to material and/or surface properties, implantation positions and surgical technique, it must be appreciated that this type of anchoring element, with its depot for providing the substance and with a separate filter element, is less attractive for permanent anchoring when it is used as a conventional implant element. Specifically, the introduction of the active substance in solid form or liquid form in a specific depot and a filter element, through which the active substance is allowed to diffuse, is less suitable and means that this type of implant arrangement is more suited for test purposes than for long-term clinical use.
In connection with implants of the type in question, it is important to establish an appropriate substance layer function at and in connection with the implant. The main object of the invention is to solve this problem, among others.
It is important to be able to use tried and tested experience with proven and effective implant structures without essentially affecting these in other respects. The invention solves this problem too.
In connection with clinically well-designed implants, it is important to be able to achieve an effective use and release function for the bioactive substance in question, all of which substance must be able to be used effectively. In various designs, it is also important to be able to control the release function during the incorporation process, for example so that an initially high release function is available during a first time period and a lower release function is obtained during a second time period, or vice versa. The variations in question must be able to be effected by choice of differently structured implants in terms of the support function for the bioactive substance arranged in the respective implant. The invention solves this set of problems too.
One object of the invention is thus to combine the properties of clinically efficient implant elements and clinically efficient supports for growth factors, by modifying the geometry of existing implant elements in order to obtain secure containment of the substance in the element. Such a novel implant element can permit rapid incorporation of surrounding tissue and stable fixation even in non-optimal bone qualities, and it does this by virtue of the stimulation activity from the growth factors which are released from the support or body.
A further object of the invention is to make available an implant element with an external structure which is similar to or corresponds to the clinically efficient implant elements, so-called fixtures, which permit positioning of efficient supports or bodies with respective growth factors and a sought release of these growth factors into the tissue which is stored in the body of the implant element. Such a combination of implant element and support permits stimulation of bone growth in the tissue surrounding the implant element and also rapid incorporation and stable fixation of the implant elements in mineralized tissue.
The features which can principally be regarded as characterizing a method according to the invention are that the implant is designed with an internal space and, if appropriate, one or more channels and/or recesses leading from the internal space to the outside or outside part of the implant facing towards the structure, that one or more bodies comprising the bioactive substance are designed to cooperate with the bone and/or tissue structure surrounding the implant so as to be able to release the bioactive substance to the said surrounding structure. Further characteristics are that the said body or bodies is/are applied in the said space and, if appropriate, also in one or more of the said channels and/or recesses, in order thereby to be exposed to the said surrounding structure and deliver the bioactive substance to the latter during the said period.
An arrangement according to the invention can principally be regarded as being characterized in that the implant is designed with one or more internal spaces and, if appropriate, one or more channels or recesses which lead from the internal space or spaces to the outside of the implant. Further characteristics are that one or more bodies comprising the bioactive substance are designed to cooperate with the surrounding bone and/or tissue structure so as to release the bioactive substance to the surrounding structure, and that the body or bodies is/are assigned a position or positions in the space or spaces in which they are exposed for the said cooperation and release directly or via the said channel(s) or recess(es).
In one embodiment, each body is in the form of a spongy body or cloth saturated in or treated with the bioactive substance. Alternatively, the body can be in the form of a gel which comprises the bioactive substance. The spongy body, the cloth or the gel has a softness which permits distinct application in the space concerned while at the same time ensuring that it is held in place by frictional cooperation, adhesive cooperation, etc., with the wall of the respective space. In a preferred embodiment, the implant or implant element has clinically effective geometrical properties, for example in the shape of a cylindrical or conical solid with an outer surface which is in direct contact with the surrounding body tissue.
The bioactive substance can be a substance belonging to the superfamily TGF-β. In a preferred embodiment, the implant element has a threaded outer surface and a conically narrowing part. The latter part has an open section with an axial hole or recess for the said support or body. The hole or recess is open towards the end surface of the conical part. One or more through-holes communicate with the said axial holes and extend radially through the implant body part at right angles to the longitudinal axis of the implant in order to permit direct release of bioactive substance from the said support through the said holes or openings.
The internal space in question can thus comprise a mouth part or recess part with identical cross-sectional areas, and the body or support can fill both the internal space and the recess.
In one embodiment, the said axial hole can extend from the conical part through the main part of the implant body in order to permit release of growth factors along the length of the implant body through a suitable number of holes, channels and/or recesses in the wall of the implant element. The design and structure of the body/support or bodies/supports are chosen on the basis of a predetermined or anticipated release function. A first body can assume a first position in which the first body is arranged with a first degree of exposure, and a second body assumes a second position in which the second body has a second degree of exposure less than the first degree of exposure, or vice versa, for the purpose of permitting a controlled or optimum release function for the bioactive substance in question.
Alternatively, each body can be arranged in such a way that, in the said cooperation and release function, it varies the degree of release of the bioactive substance during the release period and, for example, effects a greater degree of release at the start of the period, or vice versa. In a further embodiment of the element, the design(s) or extent(s) of the space or spaces and any associated channels or recesses are chosen on the basis of a predetermined or anticipated release function. The channels or recesses can be arranged with different cross-sectional areas and/or extents, which means that different parts of the same body or different bodies are subject to different degrees of exposure in the release function, for the purpose of permitting a controlled or optimum release function for the implant situation in question. In a further embodiment, two bodies can be situated at a distance from each other inside the implant or implant element in order to serve different parts of the surrounding bone and/or tissue structure. The body can be absorbable in association with the release of substance. The body (bodies) can first be applied in the space and thereafter saturated with substance, which saturation can be effected with substance at different concentrations and/or quantities for the purpose of achieving a predetermined or anticipated release function.
A use according to the invention can principally be regarded as being characterized in that the implant is used to support, in one or more internal spaces, one or more bodies comprising the bioactive substance, and, via possible attachments to the space or spaces, to expose the body or bodies in order to release the bioactive substance to the surrounding bone and/or tissue structure.
By means of what has been proposed above, a novel aid is obtained for use in surgery for the purpose of obtaining effective incorporation processes in tissue, for example bone tissue. An implant according to the invention, provided with support(s) or body (bodies), can be made commercially available. Alternatively, the implant and support/body/bodies can be made available separately and joined together in situ by the person concerned, for example the surgeon. Various types of supports with different release functions and release times can be included within one range. Various types of implants or implant elements with different systems of channels and internal spaces can be made available in order to permit different release functions and release times. In addition, each body can be saturated with substance in a different quantity and/or concentration. Well-proven surgical procedures, substances and implant designs can be used in different implantation situations, which can include implantation in hard or soft dentine.
A presently proposed embodiment of a method, arrangement and use according to the present invention will be described below with reference to the attached drawings, in which
The implant element according to
The width dimension D of the body part of the implant fixture is in the range of 3.7 mm to 6.0 mm. In this illustrative embodiment, D is about 5.0 mm, and the length of the implant fixture is about 10 mm. The diameter d of the axial hole 43 is 3 mm, and the depth is 4 mm. The transverse hole 44 has a diameter of 2 mm, and the holes are drilled through the implant body. The threaded inner hole 42 for the Bránemark Systems implant fixture which is used in this particular example is 6 mm in depth along the implant axis. The inner hole 42 thus sets a limit for the maximum possible depth of the 3 mm axial hole 43.
Compared with the standardized Bránemark SystemŽ implant fixture, and also compared with other known implant fixtures of this type available on the market, the main modification in the illustrated implant fixture lies in the axial opening or hole 43. The geometric limitation on this hole is defined by the implant diameter D and the depth of the inner hole 42. The minimum depth of the hole 43 is preferably not less than 1.5×the hole diameter. However, a factor of 1.25 is used in many successful clinical cases.
A modification of the implant fixture according to
Collagen sponge materials in the form of bands, strips, blades or the like with different thicknesses and qualities are available on the market. A punch (not shown) is used to make bodies from the sponge material, in this case circular units with a diameter matching the diameter d of the axial hole 43.
The collagen part is fitted by hand into the hole 43 of diameter 3 mm in the implant body. A number of tests have been carried out to obtain reliable fixing of the sponge, in which tests the sponge was either dry or saturated with bioactive substance. These tests showed that the diameter dsp ought to be in the range of 3.0 mm <dsp>3.2 mm, both in the dry state and in the wet state.
The secure fixing of the sponge thus makes it possible for liquid containing growth factors to be added to the sponge after the latter has been fitted in the axial hole 43. The modified design of the implant makes it possible to release growth factors through the three holes or openings shown, namely the axial opening 43 and the two perpendicular openings 44. In accordance with the chosen terminology used in the attached patent claims, the recess or hole 43 constitutes an inner space for the body or support. The outer part of the space 43 can be regarded as constituting a channel adjacent to the actual space. In the present case according to
As the growth factors are released to the surrounding bone or surrounding tissue in accordance with the above, it stimulates bone growth or bone growth introduction in the area of the implant. As the collagen sponge is absorbable in itself, it is replaced by newly formed bone within the implant during the absorption process.
As regards the growth factors or the biological substances, these are applied to the sponge in the form of a liquid. A conventional injection instrument or hand pump instrument can be used to apply the desired quantity of liquid to the sponge. As regards the BMP mentioned earlier, this is a human protein which stimulates bone growth and is an example of the growth factors which can be used in the present invention. In particular, it is possible to use known growth factors of the types BMP 2 and BMP 4 which have been identified by the Genetics Institute INC as being suitable in this case. Suitable doses can be obtained from combined systems of implants and sponges with added substance, depending on the status of the bone in the implantation site, which can vary considerably from one case to another. Different concentrations of substance can be applied to the sponge in order to effect a considerable increase in bone growth in the area of the implant.
As regards the structure of the modified implant element which has been described thus far, it will be appreciated that instead of two radial holes 44 at right angles to each other, it is also possible to use other configurations of holes or channels which communicate with the axial hole 43 and open out onto the threaded outer surface. In the illustrative embodiment shown, the release of growth factors is more or less concentrated in the area around the pointed part of the implant body. In the case of an implant element without the said threaded upper hole for a tightening screw, i.e. an implant element which is designed for an external tightening means, or with only a short hole 42, the axial hole 43 can be made much deeper and can extend through the head part of the longitudinal implant body. In such a case, the growth factors can be released along the length of the implant element, through a suitable number of holes or channels 46 in the wall of the implant element (see FIG. 9). Alternatively, the sponge support can also be designed as a rod, or one or more sponge strips can be fitted in such a longitudinal hole or in the channel itself.
The invention is not limited to the embodiment described above by way of example, and instead it can be modified within the scope of the attached patent claims and the inventive concept. Thus, for example, the invention is not limited to the bodies or supports in the embodiment described above. Supports in the form of gels, solid bodies, liquids or the like can be used, provided that their dimensions and/or the viscosity permits fixing to the implant configuration in question. In the illustrative embodiment, a standard fixture has been modified in order to permit insertion of a suitable support for bioactive substances, in order to obtain a combination of implant and support which permits advantageous release of the bioactive substances into the tissue surrounding the implant element.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4175326 *||Oct 26, 1977||Nov 27, 1979||Forsyth Dental Infirmary For Children||Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases|
|US4685883 *||Jul 26, 1985||Aug 11, 1987||Jernberg Gary R||Local delivery of chemotherapeutic agents for the treatment of periodontal disease|
|US4744755 *||Aug 13, 1986||May 17, 1988||Ross Systems Corporation||Dental implant and method for installing same|
|US4764377 *||Feb 13, 1987||Aug 16, 1988||The Forsyth Dental Infirmary For Children||Intra-pocket drug delivery devices for treatment of periodontal diseases|
|US4959052 *||Apr 24, 1989||Sep 25, 1990||Georg Wiegner||Applicator for dispensing active substances|
|US4994273 *||Jul 20, 1989||Feb 19, 1991||Merck & Co., Inc.||Solubility modulated drug delivery device|
|US5059123 *||Oct 18, 1990||Oct 22, 1991||Jernberg Gary R||Periodontal barrier and method for aiding periodontal tissue regeneration|
|US5458884 *||Aug 16, 1993||Oct 17, 1995||Britton; Peter||Bioerodible device for administering active ingredients|
|US5496559 *||Apr 6, 1992||Mar 5, 1996||Sumitomo Pharmaceuticals Company, Limited||Porous solid formulations containing proteinaceous physiologically active substances|
|US5700479 *||Nov 10, 1994||Dec 23, 1997||Guidor Ab||Surgical element and method for selective tissue regeneration|
|US5702695 *||Nov 14, 1994||Dec 30, 1997||Mcgill University||Osseointegration promoting implant composition, implant assembly and method therefor|
|US6132214 *||Dec 10, 1996||Oct 17, 2000||Jouko Suhonen||Medical implant|
|US6413089 *||Feb 10, 1999||Jul 2, 2002||Arthur Ashman||Immediate post-extraction implant|
|US6530896 *||Jul 24, 2000||Mar 11, 2003||James B. Elliott||Apparatus and method for introducing an implant|
|US20010004711 *||Jan 25, 1999||Jun 21, 2001||Richard J. Lazzara||Infection-blocking dental implant|
|US20030003128 *||Dec 18, 2000||Jan 2, 2003||Piero Chiarelli||Dental prosthesis with means for the release of active substances|
|US20040053196 *||Sep 12, 2003||Mar 18, 2004||Woodwelding Ag||Implant to be implanted in bone tissue or in bone tissue supplemented with bone substitute material|
|US20040209228 *||Apr 21, 2002||Oct 21, 2004||Daniel Ilan||Polymeric dental implant|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7510397||Sep 15, 2005||Mar 31, 2009||Hochman Mark N||Method and apparatus for performing maxillary sinus elevation|
|US7615070 *||Apr 20, 2004||Nov 10, 2009||Spineco, Inc.||Electro-stimulation and medical delivery device|
|US8551124 *||Apr 20, 2007||Oct 8, 2013||Stryker Trauma Gmbh||Implantation pin, fixation device and method for implanting the implantation pin|
|US8657601 *||Jun 26, 2002||Feb 25, 2014||Nobel Biocare Services Ag||Implant for example dental implant|
|US8728134||May 29, 2013||May 20, 2014||Stryker Trauma Gmbh||Implantation pin, fixation device and method for implanting the implantation pin|
|US8814569 *||Oct 14, 2005||Aug 26, 2014||Nobel Biocare Services Ag||Fixture for anchoring in jaw bone|
|US9095396 *||Jul 30, 2012||Aug 4, 2015||Zimmer Dental, Inc.||Porous implant with non-porous threads|
|US9220534||Apr 27, 2009||Dec 29, 2015||Stryker Trauma Gmbh||Implantation pin kit and method for implanting an implantation pin|
|US20040243130 *||Apr 20, 2004||Dec 2, 2004||Spineco, Inc., An Ohio Corporation||Electro-stimulation and medical delivery device|
|US20050221258 *||Jun 26, 2002||Oct 6, 2005||Nobel Biocare Ab||Implant for example dental implant|
|US20060078847 *||Nov 29, 2005||Apr 13, 2006||Kwan Norman H||Dental implant system and additional methods of attachment|
|US20060084034 *||Sep 15, 2005||Apr 20, 2006||Hochman Mark N||Method and apparatus for performing maxillary sinus elevation|
|US20060093646 *||Oct 28, 2005||May 4, 2006||Cima Michael J||Orthopedic and dental implant devices providing controlled drug delivery|
|US20060115791 *||Oct 14, 2005||Jun 1, 2006||Carvalho Paulo M||Fixture for anchoring in jaw bone|
|US20070016163 *||May 4, 2006||Jan 18, 2007||Microchips, Inc.||Medical and dental implant devices for controlled drug delivery|
|US20070088442 *||Oct 16, 2006||Apr 19, 2007||Microchips, Inc.||Passive wear-indicating sensor for implantable prosthetic device|
|US20080262517 *||Apr 20, 2007||Oct 23, 2008||Stryker Trauma Gmbh||Implantation pin, fixation device and method for implanting the implantation pin|
|US20090298015 *||Dec 18, 2008||Dec 3, 2009||Global Implant Solutions, Llc||Digital Abutment For Dental Implant System|
|US20100015571 *||Jun 24, 2009||Jan 21, 2010||Global Implant Solutions, Llc||Flexible Abutment For Use With A Dental Implant|
|US20100221681 *||Apr 5, 2010||Sep 2, 2010||Mark Hochman||Method and apparatus for peristaltic pump and surgical handpiece with pressure regulated fluid sensing for maxillary sinus elevation|
|US20110224739 *||Apr 27, 2009||Sep 15, 2011||Stryker Trauma Gmbh||Implantation pin kit and method for implanting an implantation pin|
|US20130022943 *||Jul 30, 2012||Jan 24, 2013||Zimmer Dental, Inc.||Porous implant with non-porous threads|
|U.S. Classification||433/201.1, 424/435, 433/174|
|International Classification||A61F2/02, A61C8/00, A61L27/24, A61F2/00, A61L27/54, A61F2/28|
|Cooperative Classification||A61F2002/30062, A61L27/54, A61F2002/2817, A61L2300/414, A61L2300/602, A61F2210/0004, A61C8/00, A61F2310/00365, A61F2002/2889, A61L27/24, A61F2/2803|
|European Classification||A61C8/00, A61L27/24, A61L27/54|
|Feb 28, 2002||AS||Assignment|
Owner name: NOBEL BIOCARE AB, SWEDEN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HALL, JAN;LOOF, LENNART;REEL/FRAME:012768/0992
Effective date: 20011218
|Dec 16, 2008||FPAY||Fee payment|
Year of fee payment: 4
|May 2, 2012||AS||Assignment|
Owner name: NOBEL BIOCARE SERVICES AG, SWITZERLAND
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOBEL BIOCARE AB;REEL/FRAME:028140/0176
Effective date: 20100915
|Dec 10, 2012||FPAY||Fee payment|
Year of fee payment: 8
|Dec 8, 2016||FPAY||Fee payment|
Year of fee payment: 12